Cannassure Therapeutics Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
Sales 2022 | 33.78 121.66 | Sales 2023 | 11 39.61 | Capitalization | 4M 14.41M |
---|---|---|---|---|---|
Net income 2022 | -5M -18.01M | Net income 2023 | -1M -3.6M | EV / Sales 2022 | 1,023,292 x |
Net Debt 2022 | 29.96M 108M | Net Debt 2023 | 2.43M 8.77M | EV / Sales 2023 | 585,038 x |
P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 86.6% |
Managers | Title | Age | Since |
---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 22-03-30 |
Nir Peles
CHM | Chairman | 51 | 18-12-03 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 70 | 19-06-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 72 | 18-12-03 |
Nir Peles
CHM | Chairman | 51 | 18-12-03 |
Varda Kalal
BRD | Director/Board Member | 56 | 22-02-13 |
1st Jan change | Capi. | |
---|---|---|
+13.17% | 228M | |
-14.43% | 177M | |
+34.30% | 176M | |
-28.57% | 122M | |
+300.00% | 121M | |
+32.46% | 120M | |
+92.14% | 112M | |
-54.07% | 97.05M | |
+7.69% | 94.1M |